These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7818753)

  • 1. Dose to breast in breast undergoing mantle treatments.
    Rajaratnam S; Nisce LZ; Avanzato J
    Med Dosim; 1994; 19(3):145-6. PubMed ID: 7818753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of radiation dose delivered to breast tissue during mantle field irradiation for Hodgkin's disease.
    Kowalski A; Smith S
    Med Dosim; 1998; 23(1):31-6. PubMed ID: 9586717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin's disease.
    Cygler J; Ding GX; Kendal W; Cross P
    Med Dosim; 1997; 22(2):135-7. PubMed ID: 9243468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mantle irradiation with 18 MeV photons. Measurement and calculation of dose distribution].
    Urgesi A; Ragona R; Anglesio S; Monetti U; Rossi G
    Radiol Med; 1985; 71(1-2):56-8. PubMed ID: 3927446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of a radiation technic with an anterior mantle-shaped field and 10 MV photons].
    Micheletti E; Verzeletti L
    Radiol Med; 1983; 69(7-8):566-71. PubMed ID: 6422516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of Hodgkin's disease in early pregnancy: embryo dose measurements.
    Mazonakis M; Varveris H; Fasoulaki M; Damilakis J
    Radiother Oncol; 2003 Mar; 66(3):333-9. PubMed ID: 12742274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the dosimetry for mantle field therapy using 4 MV X-rays and its routine application.
    Nair R; Wrede DE; Kartha M; Batley F
    Rev Interam Radiol; 1979 Oct; 4(4):169-72. PubMed ID: 547376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involved field radiation for Hodgkin's lymphoma: the actual dose to breasts in close proximity.
    Dabaja B; Wang Z; Stovall M; Baker JS; Smith SA; Khan M; Ballas L; Salehpour MR
    Med Dosim; 2012; 37(4):374-82. PubMed ID: 22513213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of Hodgkin's disease therapy using a 4 MV linear accelerator.
    Gray L; Prosnitz LR
    Radiology; 1975 Aug; 116(02):423-8. PubMed ID: 807947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scatter dose from tangential breast irradiation to the uninvolved breast.
    Muller-Runkel R; Kalokhe UP
    Radiology; 1990 Jun; 175(3):873-6. PubMed ID: 2343139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of contralateral breast doses from 1/2 beam block and isocentric treatment techniques for patients treated with primary breast irradiation with 60CO.
    Tercilla O; Krasin F; Lawn-Tsao L
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):205-10. PubMed ID: 2745194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative mantle irradiation technique using 3D CT- based treatment planning for female patients with Hodgkin's disease.
    Vuong T; Parker W; Patrocinio HJ; Fava P; Parmar D; Evans MD; Freeman CR
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):739-48. PubMed ID: 10837959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast reconstruction using tissue expanders and implants in Hodgkin's patients with prior mantle irradiation.
    Bacilious N; Cordeiro PG; Disa JJ; Hidalgo DA
    Plast Reconstr Surg; 2002 Jan; 109(1):102-7. PubMed ID: 11786799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose to the contralateral breast due to primary breast irradiation.
    Fraass BA; Roberson PL; Lichter AS
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):485-97. PubMed ID: 3972661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hypothyroidism related to mantle irradiation for Hodgkin's disease: preparative phantom study.
    Marcial-Vega VA; Order SE; Lastner G; Cole PD; LaFrance N; O'Neill M
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):613-8. PubMed ID: 2318694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle field dosimetry comparing 4 MV with cobalt 60.
    Gray L; Prosnitz LR
    Radiology; 1975 Aug; 116(02):429-32. PubMed ID: 807948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added aluminum shielding to attenuate back scatter electrons from intra-oral lead shields.
    Weidlich GA; Nuesch CE; Fuery JJ
    Med Dosim; 1996; 21(3):165-7. PubMed ID: 8899682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
    Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry of the breast for determining carcinogenic risk in mantle irradiation.
    Zellmer DL; Wilson JF; Janjan NA
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1343-51. PubMed ID: 1938534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose delivered from Varian's CBCT to patients receiving IMRT for prostate cancer.
    Wen N; Guan H; Hammoud R; Pradhan D; Nurushev T; Li S; Movsas B
    Phys Med Biol; 2007 Apr; 52(8):2267-76. PubMed ID: 17404468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.